SCHEMBL10487889

SCHEMBL10487889

CCOC(=O)Cn1c(=O)n(Cc2ccc(Br)cc2F)c(=O)c2cccc(Cl)c21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.52
AKR1A1 P14550 1/20 0.52
LMNA P02545 3/20 0.48
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ATM Q13315 1/20 0.44
TSHR P16473 3/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
CHRM5 P08912 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.40
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
CNR2 P34972 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10487995 0.88 AKR1A1 (0.47) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL10488000 0.87 AKR1B1 (0.67) AKR1B1AKR1A1MEN1KMT2AMAPT
SCHEMBL10488091 0.85 AKR1A1 (0.52) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL10487808 0.85 AKR1B1 (0.60) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL10487846 0.85 AKR1B1 (0.57) AKR1B1AKR1A1ALDH1A1MEN1KMT2A
SCHEMBL10487913 0.83 AKR1B1 (0.64) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL7860390 0.83 AKR1B1 (0.76) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL10487906 0.83 AKR1A1 (0.65) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL10487822 0.82 AKR1B1 (0.56) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2
SCHEMBL9534320 0.81 MEN1 (0.60) AKR1B1AKR1A1LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4883800-A DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-11-28 US disclosed
US-4734419-A Quinazoline derivatives, compositions thereof and their use in treating diabetic complications FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-29 US disclosed
EP-0218999-A2 New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-04-22 EP disclosed